111 related articles for article (PubMed ID: 37024021)
1. The dual role of C/EBPδ in cancer.
Hartl L; Duitman J; Bijlsma MF; Spek CA
Crit Rev Oncol Hematol; 2023 May; 185():103983. PubMed ID: 37024021
[TBL] [Abstract][Full Text] [Related]
2. The many faces of C/EBPδ and their relevance for inflammation and cancer.
Balamurugan K; Sterneck E
Int J Biol Sci; 2013; 9(9):917-33. PubMed ID: 24155666
[TBL] [Abstract][Full Text] [Related]
3. Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Formation.
Duitman J; Hartl L; Roelofs JJTH; Bijlsma MF; Spek CA
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439745
[TBL] [Abstract][Full Text] [Related]
4. C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
Balamurugan K; Mendoza-Villanueva D; Sharan S; Summers GH; Dobrolecki LE; Lewis MT; Sterneck E
Oncogene; 2019 May; 38(20):3765-3780. PubMed ID: 30262865
[TBL] [Abstract][Full Text] [Related]
5. CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional Programs.
Spek CA; Aberson HL; Butler JM; de Vos AF; Duitman J
Cells; 2021 Aug; 10(9):. PubMed ID: 34571881
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
Tang D; Sivko GS; DeWille JW
Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
[TBL] [Abstract][Full Text] [Related]
7. CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein.
Valente T; Dentesano G; Ezquerra M; Fernandez-Santiago R; Martinez-Martin J; Gallastegui E; Domuro C; Compta Y; Martí MJ; Bachs O; Márquez-Kisinousky L; Straccia M; Solà C; Saura J
Cell Death Differ; 2020 Feb; 27(2):509-524. PubMed ID: 31209363
[TBL] [Abstract][Full Text] [Related]
8. The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.
Mendoza-Villanueva D; Balamurugan K; Ali HR; Kim SR; Sharan S; Johnson RC; Merchant AS; Caldas C; Landberg G; Sterneck E
Oncogene; 2016 Dec; 35(48):6166-6176. PubMed ID: 27181204
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.
Sarkar TR; Sharan S; Wang J; Pawar SA; Cantwell CA; Johnson PF; Morrison DK; Wang JM; Sterneck E
Mol Cell Biol; 2012 Jan; 32(2):320-32. PubMed ID: 22037769
[TBL] [Abstract][Full Text] [Related]
10. PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells.
Sheshadri N; Poria DK; Sharan S; Hu Y; Yan C; Koparde VN; Balamurugan K; Sterneck E
Cell Death Dis; 2021 Nov; 12(11):1038. PubMed ID: 34725321
[TBL] [Abstract][Full Text] [Related]
11. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control.
Sivko GS; Sanford DC; Dearth LD; Tang D; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):844-56. PubMed ID: 15389878
[TBL] [Abstract][Full Text] [Related]
12. The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.
Balamurugan K; Wang JM; Tsai HH; Sharan S; Anver M; Leighty R; Sterneck E
EMBO J; 2010 Dec; 29(24):4106-17. PubMed ID: 21076392
[TBL] [Abstract][Full Text] [Related]
13. Eicosapentaenoic acid demethylates a single CpG that mediates expression of tumor suppressor CCAAT/enhancer-binding protein delta in U937 leukemia cells.
Ceccarelli V; Racanicchi S; Martelli MP; Nocentini G; Fettucciari K; Riccardi C; Marconi P; Di Nardo P; Grignani F; Binaglia L; Vecchini A
J Biol Chem; 2011 Aug; 286(31):27092-102. PubMed ID: 21659508
[TBL] [Abstract][Full Text] [Related]
14. Regulation of mouse chondrocyte differentiation by CCAAT/enhancer-binding proteins.
Okuma T; Hirata M; Yano F; Mori D; Kawaguchi H; Chung UI; Tanaka S; Saito T
Biomed Res; 2015; 36(1):21-9. PubMed ID: 25749148
[TBL] [Abstract][Full Text] [Related]
15. C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC.
Hartl L; Roelofs JJTH; Dijk F; Bijlsma MF; Duitman J; Spek CA
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675048
[TBL] [Abstract][Full Text] [Related]
16. Peptidoglycan enhances transcriptional expression of CCAAT/enhancer-binding protein delta gene in mouse macrophages.
Huang YC; Chang WC; Su JG; Cai JL; Chen CC; Hung JJ; Liu YW
J Biomed Sci; 2007 May; 14(3):407-18. PubMed ID: 17273900
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer binding protein δ in macrophages contributes to immunosuppression and inhibits phagocytosis in nasopharyngeal carcinoma.
Hsiao YW; Li CF; Chi JY; Tseng JT; Chang Y; Hsu LJ; Lee CH; Chang TH; Wang SM; Wang DD; Cheng HC; Wang JM
Sci Signal; 2013 Jul; 6(284):ra59. PubMed ID: 23861541
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter.
Shin CS; Jeon MJ; Yang JY; Her SJ; Kim D; Kim SW; Kim SY
J Mol Endocrinol; 2006 Jun; 36(3):531-46. PubMed ID: 16720721
[TBL] [Abstract][Full Text] [Related]
19. CCAAT/enhancer binding protein delta (C/EBPδ) demonstrates a dichotomous role in tumour initiation and promotion of epithelial carcinoma.
Sowamber R; Chehade R; Bitar M; Dodds LV; Milea A; Slomovitz B; Shaw PA; George SHL
EBioMedicine; 2019 Jun; 44():261-274. PubMed ID: 31078521
[TBL] [Abstract][Full Text] [Related]
20. CCAAT/enhancer-binding protein δ (C/EBPδ) aggravates inflammation and bacterial dissemination during pneumococcal meningitis.
Valls Serón M; Duitman J; Geldhoff M; Engelen-Lee J; Havik SR; Brouwer MC; van de Beek D; Spek CA
J Neuroinflammation; 2015 May; 12():88. PubMed ID: 25958220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
